Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new AbbVie News Center item was added regarding clarification on the EPCORE DLBCL-1 trial; at the same time, several older press releases and social posts were removed or trimmed as part of a content refresh.
    Difference
    8%
    Check dated 2026-07-25T07:43:02.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The News Center page was updated with two new items: Allergan Aesthetics’ approval for Boey in Europe and SkinMedica’s continued investment in regenerative science. At the same time, older press releases about MAVIRET and SKYRIZI approvals were removed to refresh the current news feed.
    Difference
    5%
    Check dated 2026-07-18T02:13:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new press release announces European Commission approval of TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab for relapsed/refractory follicular lymphoma, updating the News Center with a regulatory milestone. Older posts such as the CHMP opinion for Upadacitinib in non-segmental vitiligo and the AbbVie–Apogee Therapeutics acquisition were removed from the listing, refreshing the feed with more recent news.
    Difference
    8%
    Check dated 2026-07-10T22:36:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Adds three June 29, 2026 press releases about positive Phase 3 results and CHMP opinions to the News Center. Simultaneously, several older news items are removed to refresh the feed.
    Difference
    11%
    Check dated 2026-07-03T21:50:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The News Center gains several new press releases and event notices (including the Q2 earnings call and major product updates), while older stories are being removed or archived to surface newer content.
    Difference
    11%
    Check dated 2026-06-26T19:34:37.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    New items such as the June 18, 2026 dividend announcement, June 16 FDA approval for SKINVIVE, and a patient decision-making story related to CLL are added to the News Center. Older items including ASCO 2026 data and a CHMP opinion for Boey are removed.
    Difference
    10%
    Check dated 2026-06-19T17:23:16.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.